Non surgical management of ectopic pregnancy;La prise en charge non chirurgicale des grossesses extra-uterines

Tunisie Medicale

Volumn 84, Issue 6, 2006, Pages 331-339

  Kdous, Moez ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Ectopic pregnancy; Gonadotrophine chorionic hormone; Medical treatment; Methotrexate

Indexed keywords

CHORIONIC GONADOTROPIN; METHOTREXATE;

ASSAY; CONSERVATIVE TREATMENT; ECTOPIC PREGNANCY; HIGH RISK POPULATION; HUMAN; INCIDENCE; LAPAROTOMY; MEDICAL LITERATURE; MORBIDITY; MORTALITY; REVIEW; SALPINGECTOMY; TRANSVAGINAL ECHOGRAPHY; TREATMENT INDICATION;

ADULT; ANIMALS; CHORIONIC GONADOTROPIN; CLINICAL PROTOCOLS; ENZYME INHIBITORS; FEMALE; FOLIC ACID ANTAGONISTS; HUMANS; LEUCOVORIN; METHOTREXATE; PATIENT SELECTION; PREGNANCY; PREGNANCY, ECTOPIC; PROGNOSIS; RABBITS; RATS; RISK FACTORS; TIME FACTORS;

EID: 33749480922     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Mashiach, S., H.J. Carp, and D.M. Serr, Nonoperative management of ectopic pregnancy. A preliminary report. J Reprod Med, 1982; 27: 127-32.
2. Lund, J.J., Early ectopic pregnancy: comments on conservative treatment. J Obstet gynecol Br Emp, 1955; 62: 70-76.
3. Tanaka, T., et al., Treatment of interstitial ectopic pregnancy with methotrexate: report of a successful case. Fertil Steril, 1982; 37: 851-2.
4. Lund, J., Early ectopic pregnancy: comments on conservative treatment. J Obstet Gynecol Br Emp, 1955; 62: 70-76.
5. Mashiach, S., H. Carp, and D. Serr, Non operative management of ectopic pregnancy: a preliminary report. J Reprod Med, 1982; 27: 127-132.
6. Korhonen, J., U.H. Stenman, and P. Ylostalo, Low-dose oral methotrexate with expectant management of ectopic pregnancy. Obstet Gynecol, 1996; 88: 775-8.
7. Egarter, C. and P. Husslein, Treatment of tubal pregnancy by prostaglandins. Lancet, 1988; 1: 1104-5.
8. Korhonen, J., D.H. Stenman, and P. Ylostalo, Serum human chorionic gonadotrophin dynamlics during spontaneous resolution of ectopic pregnancy. Fertil Steril, 1994; 61: 632-636.
9. Atri, M., et al., Expectant Treatment of Ectopic Pregnancies: Clinical and Sonographic Predictors. AJR, 2001; 176: 123-127.
10. Cacciatore, B., et al., Transvaginal sonography and serum hCG in monitoring of preumed ectopic pregnancies selected for expectant management. Ultrasound Obstet Gynecol, 1995; 5: 297-300.
11. Goldie, J.H., L.A. Price, and K.R. Harrap, Methotrexate toxicity correlation with duration of administration plasma levels dose and excretion pattern. Eur J Cancer, 1972; 8: 409-414.
12. Fernandez, H., P. Bourget, and Y. Ville, Treatment of unruptured tubal pregnancy with methotrexate: pharmakokinetic analysis of local versus intramuscular administration. Fertil Steril, 1994; 62: 943-947.
13. Fernandez, H., P. Bourget, and Y. Ville, Treatment of unruptured pregnancy with methotrexate: pharmakokinetic analysis of local verus intramuscular administration. Fertil Steril, 1994; 62: 943-947.
14. Glock, J.L., J.V. Johnson, and J.R. Brumsted, Efficacy and safety of single-dose systemic methotrexate in the treatment of ectopic pregnancy. Fertil Steril, 1994; 62: 716-21.
15. Parker, J., A. Bisits, and A.M. Proietto, A systematic review of single-dose intramuscular methotrexate for the treatment of ectopic pregnancy. Aust N Z J Obstet Gynaecol, 1998; 38: 145-50.
16. Hajenius, P.J., et al., Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet, 1997; 350: 774-9.
17. Barnhart, K.T., et al., The medical management of ectopic pregnancy: a meta-analysis comparing "single dose" and "multidose" regimens. Obstet Gynecol, 2003; 101: 778-84.
18. Moore, K., The developing human. Philadelphia: W.B. Saunders, 1988: 50-102.
19. Milunsky, A., J.W. Graef, and M.F. Gaynor, Jr., Methotrexate-induced congenital malformations. J Pediatr, 1968; 72: 790-5.
20. Powell, H.R. and H. Ekert, Methotrexate-indueed congenital malformations. Med J Aust, 1971; 2: 1076-7.
21. Diniz, E.M., et al., [Effect, on the fetus, of methotrexate (amethopterin) administered to the mother. Presentation of a case]. Rev Hosp Clin Fac Med Sao Paulo, 1978; 33: 286-90.
22. Ross, G.T., Congenital anomalies among children born of mothers receiving chemotherapy for gestational trophoblastic neoplasms. Cancer, 1976; 37: 1043-7.
23. Lecuru, F., et al., The effect of tubal injection of methotrexate on fertility in the rabbit. Fertil Steril, 1992; 57: 422-4.
24. Perrotez, C., et al., Tissue effects of methotrexate injected into the uterine horn of pregnant female rats. Hum Reprod. 1991; 6: 480-3.
25. Kooi, S., F.H. van Etten, and H.C. Kock, Histopathology of five tubes after treatment with methotrexate for a tubal pregnancy. Fertil Steril, 1992; 57: 341-5.
26. Byrjalsen, C. and B. Toft, Medical treatment of eclopic pregnancy. Ann Chir Gynaecol, 1991; 80: 381-3.
27. Henry, M.A. and W.L. Gentry, Single injection of methotrexate for treatment of ectopic pregnancies. Am J Obstet Gynecol, 1994; 171: 1584-7.
28. Ichinoe, K., N. Wake, and N. Shinkai, Non surgical therapy to preserve oviduct function in patients with tubal pregnancies. Am J Obstet Gynecol, 1987; 156: 484.
29. Miyazaki, Y., Studies on non-surgical therapy of ectopic pregnancy, Acta Obstet Gynecol (Jpn). 1983; 58: 132-143.
30. Prevost, R.R., T.G. Stovall, and F.W. Ling, Methottrexate for treatment of unruptured ectopic pregnancy. clin Pharmacol, 1992; 11: 529-532.
31. Sauer, M.V., et al., Nonsurgical management of unruptured ectopic pregnancy: an extended clinical trial. Fertil Steril, 1987; 48: 752-5.
32. Stovall, T.G. and F.W. Ling, Single dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol, 1993; 168: 1759-1765.
33. 2 dose of methotrexate for the treatment of ectopic pregnancy. Abstract of the Scientific Oral and Poster Sessions of American Society for Reproductive Medecine, 1996. november: O-027.
34. Feichtinger, W. and P. Kemeter, Conservative treatment of ectopic pregnancy by transvaginal aspiration under sonographic control and methotrexate injection. Lancet, 1987. i: 381.
35. Hajenius, P.J., et al., Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev, 2000: CD000324.
36. Stovall, T.G., et al., Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases. Obstet Gynecol, 1991; 77: 749-53.
37. Prapas, J., et al., Conservative treatment of ectopic pregnancy with intramuscular administration of methotrexate (MTX/CV), Acta Eur Fertil, 1992; 23: 25-8.
38. Sowter, M.C., et al., A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy. Bjog, 2001; 108: 192-203.
39. Saraj, A.J., et al., Resolution of hormonal markers of ectopic gestation: a randomized trial comparing single-dose intramuscular methotrexate with salpingostomy. Obstet Gynecol, 1998; 92: 989-94.
40. Fernandez, H., et al., Randomized trial of conservative laparoscopic treatment and methotrexate administration in ectopic pregnancy and subsequent fertility. Hum Reprod, 1998; 13: 3239-43.
41. Lipscomb, G.H., et al., Management of separation pain after single-dose methotrexate therapy for ectopic pregnancy. Obstet Gynecol, 1999; 93: 590-3.
42. Fernandez, H., et al., Ultrasound-guided injection of methotrexate versus laparoscopic salpingotomy in ectopic pregnancy. Fertil Steril, 1995; 63: 25-9.
43. Fernandez, H., et al., [Role of conservative therapy and medical treatment in ectopic pregnancy: literature review and clinical trial comparing medical treatment and conservative laparoscopic treatment]. Contracept Fertil Sex, 1996; 24: 297-302.
44. Fernandez, H., et al., Methotrexate treatment of ectopic pregnancy: 100 cases treated by primary transvaginal injection under sonographic control. Fertil Steril, 1993; 59: 773-7.
45. Tulandi, T., et al., Transvaginal intratubal methotrexate treatment of ectopic pregnancy. Fertil Steril, 1992; 58: 98-100.
46. Darai, E., et al., Transvaginal intratubal methotrexate treatment of eclopic pregnancy. Report of 100 cases. Hum Reprod, 1995; 11: 420-4.
47. Tzafettas, J., et al., Transvaginal intra amniotic injection of methotrexate in early ectopic pregnancy. Early Hum Dev, 1994; 39: 101-7.
48. Fernandez, H., et al., Conservative management of ectopic pregnancy: prospective randomized clinical trial of methotrexate versus prostaglandin sulprostone by combined transvaginal and systemic administration. Fertil Steril, 1991; 55: 746-50.
49. Cohen, D.R., et al., Methotrexate: local versus intramuscular. Fertil Steril, 1996; 65: 206-7.
50. Shulman, A., et al., Conservative treatment of ectopic pregnancy and its effects on corpus luteum activity. Gynecol Obstet Invest, 1992; 33: 161-4.
51. Nazac, A., et al., Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies. Ultrasound Obstet Gynecol, 2003; 21: 181-5.
52. Risquez, F., et al., Diagnosis and treatment of ectopic pregnancy by retrograde selective salpingography and intruluminal methotrexate injection: work in progress. Hum Reprod, 1990; 5: 759-62.
53. Lipscomb, G.H., et al., Oral methotrexate for treatment of ectopic pregnancy. Am J Obstet Gynecol, 2002; 186: 1192-5.
54. Gazvani, M.R. and S.J. Emery. Mifepristone and methotrexate: the combination for medical treatment of ectopic pregnancy. Am J Obstet Gynecol, 1999; 180: 1599-600.
55. Landstrom, G., et al., Ectopic pregnancy: local medical treatment versus oral mùethotrexate therapy-a multicentre study. Abstracts of the 14th Annual Meeting of the ESCHRE, 1998(O-073).
56. Laatikainen, T., L. Tuomivaara, and K. Kaar, Comparison of a local injection of hyperosmolar solution with salpingostomy for the conservative treatment of tubal pregnancy. Fertil Steril, 1993; 60: 80-4.
57. Gljelland, K., et al., Treatment of ectopic pregnancy by local injection of hypertonic glucose: a randomized trial comparing administration by transvaginal ultrasound or laparoscopy. Acta Obstet Gynecol Scand, 1995; 74: 629-34.
58. Hordnes, K., Reproductive outcome after treatment of ectopic pregnancy with local injection of hypertonic glucose. Acta Obstet Gynecol Scand, 1997; 76: 703-5.
59. Lang, P.F. et al., Conservative treatment of ectopic pregnancy with local injection of hyperosmolar glucose solution or prostaglandin-F2 alpha: a prospective randomised study. Lancet, 1990; 336: 78-81.
60. Buster, J.E. and S.A. Carson, Ectopic pregnancy: new advances in diagnosis and treatment. Curr Opin Obstet Gynecol, 1995; 7: 168-76.
61. Stovall, T.G. and F.W. Ling, Single-dose methotrexale: an expanded clinical trial. Am J Obstet Gynecol, 1993; 168: 1759-62.
62. Brown, D.L., et al., Serial endovaginal sonography of ectopic pregnancies treated with methotrexate. Obstet Gynecol, 1991; 77: 406-9.
63. Carp, H., et al., Fertility after non surgical treatment of ectopic pregnancy. J Reprod Med, 1985; 31: 119-121.
64. Dericks-Tan, J.S.E., C. Scholtz, and H.D. Taubert, Spontaneous recovery of ectopic pregnancy: a preliminary report. Eur J Obstet Gynecol Reprod Biol. 1987; 25: 1815.
65. Garcia, A.J., et al., Expectant management of presumated ectopic pregnancies. Fertil Steril, 1987; 48: 395-400.
66. Fernandez, H., et al., Spontaneous resolution of ectopic pregnancy. Obstet Gynecol, 1988; 71: 171-4.
67. Ylostalo, P., et al., Expectant management of ectopic pregnancy. Obstet Gynecol, 1992; 80: 345-8.
68. Korhonen, J., U.H. Stenman, and P. Ylostalo, Serum human chorionic gonadotrophin dynamics during spontaneous resolution of ectopic pregnancy. Fertil Steril, 1994; 61: 632-636.
69. Shalev, E., et al., Limited role for intratubal methotrexate treatment of ectopic pregnancy. Fertil Steril, 1995; 63: 20-4.
70. Hahlin, M., J. Thorburn, and I. Bryman, The epectant management of early pregnancies of uncertain site. Hum Reprod, 1995; 10: 1223-7.
71. Trio, D., et al., Prognostic factors for successful expectant management of ectopic pregnancies. Fertil Steril, 1995; 63: 469-72.
72. Ankum, W.M., et al., Suspected ectopic pregnancy: what to do when human chorionic gonadotrophin are below the discriminatory zone? J Reprod Med, 1995; 40: 525-8.
73. Atri, M., et al., Ectopic pregnancy: evolution after treatment with transvaginal methotrexate. Radiology, 1992; 185: 749-53.
74. Mol, B.W., et al., Treatment of tubal pregnancy in the netherlands: an economic comparison of systemic methotrexate administration and laparoscopic salpingostomy. Am J Obstet Gynecol, 1999; 181: 945-51.
75. Nieuwkerk, P.T., et al., Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate. Fertil Steril, 1998; 70: 518-22.
76. Nieuwkerk, P.T., et al., Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients' health-related quality of life. Fertil Steril, 1998; 70: 511-7.
77. Dias Pereira, G., et al., Fertility outcome after systemic methotrexate and laparoscopic salpingostomy for tubal pregnancy. Lancet, 1999; 353: 724-5.
78. Sowter, M.C., C.M. Farquhar, and G. Gudex, An economic evaluation of single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured ectopic pregnancy. Bjog, 2001; 108: 204-12.